Glenmark Specialty SA receives USFDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation Read more
USFDA approval and continuous manufacturing adoption mark breakthrough year for STEER World in pharma Read more
Alembic Pharmaceuticals gets USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004% Read more
USFDA grants Orphan Drug Designation (ODD) to Zydus’ Desidustat for treatment of beta-thalassemia Read more